News

  1. Phillips-Medisize Expands Product Portfolio With Launch Of A Pen Injector Platform Designed To Lower Pharma Costs, Risks And Market Barriers 2/1/2023

    Phillips-Medisize, a Molex company and leader in the design and manufacture of drug delivery, diagnostic and MedTech devices, has expanded its product portfolio with the introduction of a disposable pen injector.

  2. Lilly Plans To Invest Additional $450M At Manufacturing Site In Research Triangle Park 1/24/2023

    Eli Lilly and Company (NYSE: LLY) today announced plans to invest an additional $450 million and create at least 100 new jobs to expand its manufacturing capacity at the company's Research Triangle Park facility. The expansion includes additional parenteral filling, device assembly and packaging capacity to support an increased demand for Lilly's incretin products that treat diabetes.

  3. Stevanato Group Collaborates With Transcoject To Provide Pre-Fillable Syringe Polymer Options For Pharma 1/24/2023

    Stevanato Group S.p.A. a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its latest collaboration with Transcoject GmbH, a medical device and pharma packaging solutions company.

  4. Parenteral Drug Association Announces New EU GMP Annex 1 Implementation Interest Group 1/20/2023

    PDA is pleased to announce the formation of the Annex 1 Implementation Interest Group, which will begin meeting in February.

  5. Catalent And Ethicann Sign Development And License Agreement For New Fast-Dissolve Cannabinoid-Based Treatments 1/12/2023

    Catalent, the global leader in enabling the development and supply of better treatments across multiple modalities, and Ethicann Pharmaceuticals Inc., a Canadian/U.S. specialty pharmaceutical company focused on the development of high-value cannabinoid drug therapies, today announced that the companies had executed a development and license agreement to develop Ethicann’s clinical drug pipeline using Catalent’s proprietary Zydis orally disintegrating tablet (ODT) technology.

  6. Argonaut Manufacturing Services Set To Expand Drug Product Fill/Finish Capabilities With Significant Capital Investment 1/10/2023

    Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, today announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.

  7. Oncorus Announces Research Collaboration With Daewoong Pharmaceutical For The Development Of Lipid Nanoparticle Formulations For mRNA Drug Candidates 1/4/2023

    Oncorus, Inc. (Nasdaq: ONCR), an RNA medicines company focused on developing intravenously administered, self-amplifying RNA to transform outcomes for cancer patients, and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620), a leading South Korean pharmaceutical company, today announced a research collaboration for the discovery and development of novel lipid nanoparticle (LNP) formulations for mRNA drug candidates.

  8. Berkshire Sterile Expands Analytical Testing And Development Services 12/19/2022

    Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand their testing and development capabilities.

  9. Formulated Solutions Signs Agreement To Acquire 455,000ft2 US FDA Approved Drug Production Site 12/19/2022

    Formulated Solutions, a Florida-based Contract Development and Manufacturing Organization (CDMO) supporting consumer-centric innovation, expert development, and cost-effective production of consumer healthcare solutions, announced an agreement to acquire a newly updated 455,000 ft2 FDA approved pharmaceutical liquids, semi solids, aerosol, BoV, and metered dose nasal spray production facility located in Cleveland, TN.

  10. Hovione And GEA Announce A Strategic Collaboration To Advance Continuous Tableting 12/14/2022

    Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years.